Albany, NY -- (SBWire) -- 10/27/2016 --The market of antiviral drugs is segmented on the basis of products, such as Hepatitis-C antivirals, HIV antivirals, Herpes antivirals, Hepatitis-B antivirals, Influenza antivirals and others. The market is also segmented on the basis of enzyme specific actions, such as DNA polymerase inhibitors, NS3 Protease inhibitors, reverse transcriptase inhibitors and others. The market is also segmented on the basis of geography, such as North America, Europe, Asia-Pacific and Rest of the World (RoW). The U.S. is the biggest market for antiviral drugs, followed by the U.K. and Japan. However, Asia-Pacific and African regions of the world are considered as the most promising markets in the forecast period. Virus is a micro-infectious agent that replicates only in the living cells,which results in prevalence of disease. Antiviral drugs are a class of medications that are specifically used to treat the viral infections. Usually, antivirals inhibit the growth of pathogens.
View exclusive Global strategic Business Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2306
Some of the key factors driving the antiviral drugs market are strong R&D activities, increase in healthcare expenditure, increased prevalence of the life-threatening viral diseases and increase in the public awareness. According to WHO, as of October 2013, there are around 35.3 million people in the world, infected with HIV. Hence, increased viral infection incidences is one of the prominent factors that drives the market growth. Due to strong R&D activities, newer and advanced formulations and treatments, such as combination therapy, vaccines and others, are being introduced in the market. Thus, strong R&D is one of the key factors in the market growth. On the other hand, high cost of R&D and therapy, high risk of failure and government austerity are some of threats expected to hinder the growth of market.
Read Full Report: http://www.transparencymarketresearch.com/antivirals-market.html
Some of the major players operating in this market includes GlaxoSmithKline, plc. Abbott Laboratories, AstraZeneca AB, BoehringerIngelheim Corporation, Novartis International AG, Merck and Co. Inc., Johnson & Johnson amongst others.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
North America
Asia Pacific
Europe
Rest of the World
This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter's five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: 518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
Antivirals Market: Current Market Trends, Market Structure, Market Projections for Upcoming Years
Transparency Market Research Report Added "Antivirals Market" to its database.